跳至主要内容
临床试验/2024-512571-12-00
2024-512571-12-00招募中4 期

Oil- versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized controlled trial (H2Oil-2 study)

Amsterdam UMC Stichting9 个研究点 分布在 1 个国家目标入组 499 人开始时间: 2024年11月29日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
499
试验地点
9
主要终点
The primary outcome is conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization.

研究概览

简要总结

Conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment Phase
盲法
None

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者

入选标准

  • Ovulation disorders (ovulation disorders will be defined as less than 8 menstrual cycles per year)
  • High risk for tubal pathology (high risk for tubal pathology will be defined as a positive chlamydia infection, a pelvic inflammatory disease, known endometriosis, abdominal surgery (including tubectomy for ectopic pregnancy and appendectomy) and/or peritonitis in the medical history)
  • Above 38 years of age

排除标准

  • Iodine allergy
  • Male subfertility defined as a post-wash total motile sperm count < 1 x10^6 spermatozoa/ml
  • Not willing or able to sign the consent form
  • Endocrine disorders as diabetes, hyperthyroidism or hyperprolactinemia (except for well managed hypothyroidism with TSH between 0.3 and 2.5mIU/l)

结局指标

主要结局

The primary outcome is conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization.

The primary outcome is conception leading to live birth, with a positive pregnancy test preceding the pregnancy within 6 months after randomization.

次要结局

  • Biochemical pregnancy
  • Clinical pregnancy
  • Ongoing pregnancy
  • Miscarriage
  • Ectopic pregnancy
  • Multiple pregnancy
  • Time to pregnancy
  • Complications following HSG (infection, intravastion)
  • Pregnancy outcomes (f.e. birth weight)
  • Pregnancy complications
  • Stillbirth
  • Thyroid function of the woman (before and 1 month after HSG)
  • Neonatal outcomes
  • Additional fertility treatments (Intra-uterine insemination, IVF, IVF/ICSI)
  • Costs within 6 months after randomization
  • Thyroid function of neonate (determined by heelprick)

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Prof. dr. V. Mijatovic

Scientific

Amsterdam UMC Stichting

研究点 (9)

Loading locations...

相似试验